 | Up a level |
Pavel, M; Öberg, K; Falconi, M; Krenning, E P; Sundin, A; Perren, A.; Berruti, A (2020). Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 31(7), pp. 844-860. Elsevier 10.1016/j.annonc.2020.03.304
Knigge, U; Capdevila, J; Bartsch, D K; Baudin, E; Falkerby, J; Kianmanesh, R; Kos-Kudla, B; Niederle, B; Nieveen van Dijkum, E; O'Toole, D; Pascher, A; Reed, N; Sundin, A; Vullierme, M-P; Perren, Aurel (2017). ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation. Neuroendocrinology, 105(3), pp. 310-319. Karger 10.1159/000458155
Kos-Kudla, B; O'Toole, D; Falconi, M; Gross, D; Klöppel, G; Sundin, A; Ramage, J; Oberg, K; Wiedenmann, B; Komminoth, P; Van Custem, E; Mallath, M; Papaotti, M; Caplin, M; Palma de Mallorca Consensus Conference Participiants, (Perren A) (2010). ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumors. Neuroendocrinology, 91(4), pp. 341-350. Basel: Karger 10.1159/000287255
Kwekkeboom, DJ; Krenning, EP; Scheidhauer, K; Lewington, V; Lebthai, R; Grossman, A; Vitek, P; Sundin, A; Plöckinger, U; Mallorca-Consensus-Conference, Participants; European-Neuroendocrine-Tumor, Society (2009). ENETS consensus guidelines for the standards of care in neuroendocrine tumors: somatostatin receptor imaging with (111)In-pentetreotide. Neuroendocrinology, 90(2), pp. 185-9. Basel: Karger 10.1159/000225946
Jensen, RT; Niederle, B; Mitry, E; Ramage, JK; Steinmuller, T; Lewington, V; Scarpa, A; Sundin, A; Perren, A; Gross, D; O'Connor, JM; Pauwels, S; Kloppel, G; Frascati, Consensus Conference; European, Neuroendocrine Tumor Society (2006). Gastrinoma (duodenal and pancreatic). Neuroendocrinology, 84(3), pp. 173-82. Basel: Karger 10.1159/000098009
